|
Market Closed -
Bombay S.E.
06:29:08 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 80.81 INR | +9.87% |
|
+4.99% | +96.76% |
| 08-05 | Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026 | CI |
| 08-04 | Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 18.52B 194M 168M 158M 144M 271M 275M 1.86B 725M 9.27B 729M 713M 30.93B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 194M 168M 158M 144M 271M 275M 1.86B 725M 9.27B 729M 713M 30.93B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | +9.87% | ||
| 1 week | +4.99% | ||
| Current month | +41.77% | ||
| 1 month | +32.04% | ||
| 3 months | +88.24% | ||
| 6 months | +107.10% | ||
| Current year | +96.76% |
| 1 week | 73 |  | 82.95 |
| 1 month | 51.43 | | 83.45 |
| Current year | 33.44 | | 83.45 |
| 1 year | 33.44 | | 83.45 |
| 3 years | 31.31 | | 100.8 |
| 5 years | 23.65 | | 100.8 |
| 10 years | 7.21 | | 100.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 58 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.87% | +4.99% | +73.08% | +133.15% | 423M | |
| -0.27% | +2.06% | +84.18% | +126.12% | 1,088B | |
| +0.24% | +1.69% | +49.82% | +50.67% | 629B | |
| +0.92% | +2.90% | +24.56% | +64.81% | 440B | |
| -0.88% | -0.66% | +45.09% | +36.79% | 359B | |
| -0.37% | -1.15% | +26.89% | +36.10% | 291B | |
| +0.05% | -1.20% | +2.31% | +5.34% | 245B | |
| +0.50% | +3.27% | +44.50% | +60.20% | 225B | |
| -0.42% | +1.58% | -8.48% | -51.84% | 204B | |
| +0.86% | +4.71% | +14.06% | +71.61% | 168B | |
| Average | +1.09% | +0.70% | +35.60% | +53.30% | 364.96B | |
| Weighted average by Cap. | +0.04% | +1.93% | +46.29% | +65.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 178M 155M 145M 132M 249M 253M 1.71B 666M 8.52B 669M 655M 28.42B | 18.12B 190M 165M 154M 141M 265M 269M 1.82B 709M 9.07B 713M 697M 30.25B |
| Net income | 962M 10.08M 8.73M 8.19M 7.46M 14.05M 14.27M 96.4M 37.63M 481M 37.83M 37.01M 1.61B | 1.18B 12.37M 10.72M 10.05M 9.16M 17.24M 17.52M 118M 46.19M 591M 46.43M 45.42M 1.97B |
| Net Debt | 121M 1.26M 1.09M 1.03M 936K 1.76M 1.79M 12.08M 4.72M 60.34M 4.74M 4.64M 201M | -928K -9.72K -8.43K -7.9K -7.2K -13.56K -13.77K -93.03K -36.32K -465K -36.5K -35.71K -1.55M |
Employees
1,814
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | ₹80.81 | +9.87% | 1,740,711 |
| 26-08-12 | ₹73.55 | -4.34% | 738,877 |
| 26-08-11 | ₹76.89 | -2.98% | 920,263 |
| 26-08-10 | ₹79.25 | -1.09% | 602,113 |
| 26-08-07 | ₹80.12 | +0.81% | 1,676,413 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
